World Sepsis Spotlight: The Focus
On April 23, 2024, the Global Sepsis Alliance (GSA) and the Physician-Patient Alliance for Health & Safety (PPAHS) co-hosted the 2024 World Sepsis Congress Spotlight, “Unmet Need in Sepsis Diagnosis and Therapy”. This one-day conference featured 61 speakers and moderators from 29 countries.
In 9 sessions, internationally renowned speakers, panelists, and moderators addressed the role of AI, predictive modeling in sepsis, the need for early diagnosis and treatment of sepsis in surgical patients, the role of biomarkers, personalized approaches to sepsis management, how hypervolemia increases the mortality risk in sepsis, community programs to prevent and diagnose sepsis, and much more.
World Sepsis Spotlight: The Numbers
The World Sepsis Spotlight was attended by 12,230 people from 185 countries.
Many of these attendees (and even those who did not attend the Spotlight live) have earned continuing medical education credits – 12 in all in the following courses:
- The Need for Early Diagnosis and Treatment of Sepsis in Surgical Patients
- Data, AI, and Predictive Modeling in Sepsis
- How Hypervolemia Increases the Mortality Risk in Sepsis
- Detecting Sepsis in Ventilated Patients
- Closing the Needs in Pediatric Sepsis
- Personalized Approaches to Sepsis Management
- Challenges and Solutions for Early Recognition and Treatment of Sepsis
To view the Spotlight report, please click here.
To be rewarded with CME credits – please register and view courses by going to the Spotlight CME page.
PPAHS would like to once again thank Inflammatix, Inc. for their unrestricted educational grant. Inflammatix is a pioneering diagnostics company based in Sunnyvale, California, USA, and is developing innovative diagnostics that rapidly read a patient’s immune system to improve patient care and reduce major public health burdens. Thanks to generous grants from Inflammatix and others, PPAHS can provide quality clinical educational content.